IOVA vs TROW · rev $170.7M vs P/E 12, rev $3.76B
Iovance Biotherapeutics Inc (IOVA) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
Iovance Biotherapeutics Inc (IOVA) is a biotechnology company listed on US.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported IOVA revenue for 2026-06-30 was $170.7M. Net income was -$126.4M. IOVA currently screens at market cap $1.89B.
Latest reported TROW revenue for 2026-06-30 was $3.76B. Net income was $1.13B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
IOVA currently screens at market cap $1.89B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the IOVA and TROW stock pages for the full models.
Not investment advice.